It is still not fully known through which mechanisms APOE and other genes with smaller effect impact AD risk, but brain atrophy level and cognitive function are considered intermediate phenotypes that may mediate genetic effects on AD risk. This evidence concerns the gene APOE and Alzheimer disease.